ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Curcumin: The All In One Solution, Part 2

CoQ10 — A Nutritional Powerhouse for Mitochondrial Health

How to Prevent Hearing Loss and Improve Your Hearing With Nutrition

What Are the Benefits of Vitamin K2?

Vitamin D deficiency + high fat diet = metabolic syndrome

Use Burdock Oil to Promote Healthy Hair Growth

Why You Should Take Your Apple Cider Vinegar at Night

AMA journal associates iron deficiency with hearing loss

Lutein linked to preservation of crystallized intelligence

Zinc eaten at levels found in biofortified crops reduces 'wear and tear' on DNA

 
Print Page
Email Article

Efficacy of low-level laser therapy in the management of neck pain: A systematic review and meta-analysis of randomized placebo or active-treatment controlled trials – Source: The Lancet, Dec 5, 2009

  [ 39 votes ]   [ Discuss This Article ]
By Roberta T Chow, et al. • www.ProHealth.com • December 14, 2009


[Note: to read the full text of this article free, click here. LLLT is also known as ‘cold laser therapy’ or ‘laser biostimulation’. ]

Background: Neck pain is a common and costly condition for which pharmacological management has limited evidence of efficacy and side-effects. Low-level laser therapy (LLLT) is a relatively uncommon, non-invasive treatment for neck pain, in which non-thermal laser irradiation is applied to sites of pain.

We did a systematic review and meta-analysis of randomized controlled trials to assess the efficacy of LLLT in neck pain.

Methods: We searched computerized databases comparing efficacy of LLLT using any wavelength with placebo or with active control in acute or chronic neck pain. Effect size for the primary outcome, pain intensity, was defined as a pooled estimate of mean difference in change in mm on 100 mm visual analogue scale.

Findings: We identified 16 randomized controlled trials including a total of 820 patients.

• In acute neck pain, results of two trials showed a relative risk (RR) of 1.69 (95% CI 1.22 - 2.33) for pain improvement of LLLT versus placebo. [Note: an RR of 1.0 would indicate no difference in odds of reduced pain intensity vs placebo. The RR of 1.69 would indicate a 69% greater liklihood of reduced pain in the patients receiving LLLT.]

• Five trials of chronic neck pain reporting categorical data showed an RR for pain improvement of 4.05 (2.74 - 5.98) of LLLT. [That is, 305% greater likelihood of reduced pain than with placebo, on average.]

• Patients in 11 trials reporting changes in visual analogue scale had pain intensity reduced by 19.86 mm (10.04 - 29.68). [An average improvement of nearly 20 points on a 100-point pain scale.]

• Seven trials provided follow-up data for 1 to 22 weeks after completion of treatment, with short-term pain relief persisting in the medium term with a reduction of 22.07 mm (17.42 - 26.72).

• Side-effects from LLLT were mild and not different from those of placebo.

Interpretation: We show that LLLT reduces pain:

• Immediately after treatment in acute neck pain,

• And up to 22 weeks after completion of treatment in patients with chronic neck pain.

Funding: None.

Source: The Lancet, Dec 5, 2009. 374(9705) pp1897-1908. Chow RT, Johnson MI, Lopes-Martins RAB, Bjordal JM. Nerve Research Foundation, Brain and Mind Research Institute, University of Sydney, NSW, Australia; Faculty of Health, Leeds Metropolitan University, UK; Institute of Biomedical Sciences, Pharmacology Department, University of São Paulo, Brazil; Faculty of Health and Social Science, Institute of Physiotherapy, Bergen University College, Norway; Section of Physiotherapy Science, Institute of Public Health and Primary Health Care, University of Bergen, Norway. [E-mail: robertachow@iinet.net.au]





Post a Comment

Featured Products From the ProHealth Store
Ultra EPA  - Fish Oil Optimized Curcumin Longvida® Energy NADH™ 12.5mg

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products


Article Comments



Be the first to comment on this article!

Post a Comment


 
NAD+ Ignite with Niagen

Featured Products

Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function

Natural Remedies

Dreaming of a Good Night's Sleep? Dreaming of a Good Night's Sleep?
Thyroid Health and Fibromyalgia Thyroid Health and Fibromyalgia
Astaxanthin - A Little-Known but Power-Packed Nutrient Astaxanthin - A Little-Known but Power-Packed Nutrient
Health Benefits Are Brewing in Green Tea Health Benefits Are Brewing in Green Tea
Fatigue & Fibro Fog: Could You Have a B-12 Deficiency? Fatigue & Fibro Fog: Could You Have a B-12 Deficiency?

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map